BIIB - Biogen Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - BIIB (875045)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
33 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P3+0-3-9+0
S24-1-2-5+9

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-01-09
BIIBPangia Robert WDirS - Sale+OE$329.65-5,83217,707-25%-$1,922,519
2017-12-29
BIIBVounatsos MichelCEOP - Purchase$320.55+7804,879+19%+$250,029
M
2017-11-28
BIIBDenner Alexander JDirP - Purchase$317.36+30,000423,887+8%+$9,520,800
2017-07-25
BIIBAlexander Susan HEVP Chief Legal Corp Svc, SecS - Sale$290.01-4,97422,258-18%-$1,442,510
2017-07-19
BIIBAlexander Susan HEVP Chief Legal Corp Svc, SecS - Sale$285.00-7,75827,232-22%-$2,211,030
2017-06-09
BIIBPosner Brian SDirS - Sale$256.31-1,0846,330-15%-$277,840
2017-05-01
BIIBVounatsos MichelCEOP - Purchase$271.35+1,4022,927+92%+$380,4330-4
2017-04-27
BIIBDenner Alexander JDirP - Purchase$278.50+73,858392,832+23%+$20,569,4760-3
2017-04-25
BIIBClancy Paul JEVP, CFOS - Sale$290.00-9,89210,813-48%-$2,868,680-2-2
2017-04-03
BIIBSandrock AlfredEVP CMO Neuro, NeurodegeneratS - Sale$274.08-1,9817,060-22%-$542,952-1-2-1
2017-03-13
BIIBClancy Paul JEVP, CFOS - Sale$291.55-9,89120,705-32%-$2,883,7210-6-8
2017-03-01
BIIBSandrock AlfredEVP CMO Neuro, NeurodegeneratS - Sale$290.07-9739,041-10%-$282,238-1-2-8
2017-02-27
BIIBVounatsos MichelCEOP - Purchase$285.39+1,3331,434>999%+$380,4250-1-9
D
2017-01-09
BIIBPangia Robert WDirS - Sale+OE$295.39-5,45016,628-25%-$1,609,876-4-5-10
2016-12-01
BIIBKaraboutis AdrianaEVP, Tech, Bus. Sol, Corp AffS - Sale$296.53-487,360-1%-$14,2330-1+1
2016-10-04
BIIBKaraboutis AdrianaEVP, Tech, Bus. Sol, Corp AffS - Sale$311.94-2627,579-3%-$81,728-1-4-10-13
D
2016-10-03
BIIBKaraboutis AdrianaEVP, Tech, Bus. Sol, Corp AffS - Sale+OE$313.00-3807,841-5%-$118,940-1-2-9-12
D
2016-09-22
BIIBDorsa CarolineDirS - Sale+OE$314.00-27,57017,093-62%-$8,656,980+2+1-6-11
2016-07-21
BIIBScangos George ACEOS - Sale$280.00-15765,5350%-$43,96000+10-3
2016-06-06
BIIBKoppel AdamEVP, Strategy, Bus. Dev.S - Sale$290.00-5552,402-19%-$160,950+1-3-1+16
2016-06-03
BIIBScangos George ACEOS - Sale$290.00-84265,692-1%-$244,180-13-15-16+2
M
2016-05-31
BIIBScangos George ACEOS - Sale$289.74-3,85566,534-5%-$1,116,9610-12-17+5
2016-05-25
BIIBScangos George ACEOS - Sale$280.00-15770,3890%-$43,9600+3-20+8
2016-05-02
BIIBScangos George ACEOS - Sale$274.74-48770,546-1%-$133,798+1+4+10+6
2016-04-06
BIIBKoppel AdamEVP, Strategy, Bus. Dev.S - Sale$275.00-1021,848-5%-$28,050-10-3+14
2016-04-06
BIIBScangos George ACEOS - Sale$280.00-15771,0330%-$43,960-10-3+14
2016-04-01
BIIBScangos George ACEOS - Sale$258.83-48771,190-1%-$126,050+50+3+18
2016-03-01
BIIBScangos George ACEOS - Sale$261.37-48771,677-1%-$127,287-2-5-3+14
2016-02-25
BIIBSandrock AlfredEVP CMO Neuro, NeurodegeneratS - Sale$261.90-1837,990-2%-$47,928-2+2-5+17
2016-02-25
BIIBKaraboutis AdrianaEVP, Tech, Bus. Sol, Corp AffS - Sale$261.90-848,127-1%-$22,000-2+2-5+17
2016-02-17
BIIBScangos George ACEOS - Sale$256.16-48770,604-1%-$124,750+20-4+20
2016-02-17
BIIBSandrock AlfredEVP CMO Neuro, NeurodegeneratS - Sale$256.16-7227,990-8%-$184,948+20-4+20
D
2016-02-09
BIIBSandrock AlfredEVP CMO Neuro, NeurodegeneratS - Sale+OE$246.54-8527,740-10%-$210,052-3+50+25

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top